Nurse Practitioner in Hawaiian Gardens, CA Accepting Medicare

4 Nurse Practitioner nurses found. Showing 1 - 4

Yvette Denise Holman, Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 21500 Pioneer Blvd, Hawaiian Gardens, CA 90716 Phone: 855-845-6291

Mrs. Jennifer Sheila Ponce Demaree, APRN, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 12131 Carson St, Hawaiian Gardens, CA 90716 Phone: 562-809-0299

Stacey Mah, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 22310 Wardham Ave, Hawaiian Gardens, CA 90716 Phone: 562-928-9600

Frances Abigail Perez Malantic, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 12131 Carson St, Hawaiian Gardens, CA 90716 Phone: 562-809-0299

News Archive

Prostate cancer screening programme leads to bigger fall in death rates than surrounding areas

The expected number of deaths from prostate cancer more than halved in the Tyrol after a programme was introduced to improve early detection and treatment of the disease, according to research published in April issue of the urology journal BJU International.

Bruker to acquire Michrom Bioresources

Bruker today announced that it has signed an agreement to acquire Michrom Bioresources, Inc., a 20 year old, privately owned company based in Auburn, California. Michrom provides liquid chromatography instrumentation, accessories, and consumables for applications in the life science, chemical and applied markets.

Low-carb diets effective, but may raise cholesterol levels

A synthesis of data from five previous clinical trials suggests that both low-fat and low-carbohydrate diets appear to be effective for weight loss up to one year, but low-carbohydrate diets may be linked to higher overall and LDL or "bad" cholesterol levels, according to a study in the Archives of Internal Medicine.

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.

Read more Medical News

› Verified 1 days ago